Is Southeast Asia losing the battle against dengue?
Governments in Singapore, Malaysia and Indonesia specifically have implemented measures such as...
Need Help? Talk to an Expert
+61 3 7036 0141
We source, supply, and distribute pharmaceutical products and vital medical supplies. At HL Pharma we provide invaluable regulatory expertise to international companies requiring the guidance and knowledge necessary for TGA registration and market entry of medical products and devices. We are also the exclusive Australian distributor for a number of products across Australia.
We source products from overseas not available in Australia - usually under Special Access and Authorised Prescriber Schemes.
We provide clinical trial and post clinical trial product management. Facilitating Clinical Trial approvals, Special Access Scheme or Authorised Prescriber approvals.
Looking for assistance in managing compassionate care supply? We can help - storage, supply and logistics.
Specialists in sourcing, supply, distribution and storage of pharmaceuticals and medical devices on behalf of The TGA Sponsor.
We provide international manufacturers and wholesalers assistance with product registration, entry and distribution onto the Australian market.
For the import and supply of Scheduled Medicines S2, S3, S4, S8 and S9.
HL Pharma has decades of industry knowledge and experience sourcing and supplying unregistered/unlicensed pharmaceuticals to hospitals, pharmacies, doctors, veterinarians, and pharmaceutical wholesalers. We are facilitators for healthcare providers wanting access to appropriate overseas registered products where not commercially available in Australia or where a registered product is in short supply or unavailable.
HL Pharma hold licenses to import and supply Schedule 2 (pharmacy medicine), S3 (pharmacist only medicine), S4 (prescription medicine/animal prescription medicine), S8 (controlled drug) and S9 (prohibited substance).
A trusted name in Australia, we are registered with The Victorian Department of Health and supply pharmaceuticals under the Good Distribution Practice (GDP).
Fill in the form below and we will be in touch with you shortly.
Governments in Singapore, Malaysia and Indonesia specifically have implemented measures such as...
ASX-listed Algorae Pharmaceuticals Limited (1A) recently announced its collaboration with HL...
The TGA teams up annually with medicines safety organisations and regulators around the world to...
The Guardian Exclusive: Hospitals in Melbourne’s eastern and western suburbs, and the Mornington...
HL Pharma attended the recent Operationalizing Early Access Programmes Summit. The European event...
We work with companies and manufacturers worldwide.